Critical Congenital Heart Disease in Newborn: Early Detection, Diagnosis, and Management
DOI:
https://doi.org/10.32539/bsm.v5i1.180Keywords:
congenital heart disease, duct-dependent circulation, ductus arteriosus, prostaglandinAbstract
Critical congenital heart disease (CHD) is a type of CHD that requires early intervention in the first year of life to survive. Morbidity and mortality increases significantly if newborns with critical CHD experience delay in the initial diagnosis and management. The infants may develop cyanosis, systemic hypoperfusion, or respiratory distress as the main manifestations of critical CHD. Pulse oximetry screening for early detection of critical CHD must be performed in newborns after 24 hours of age or before discharge from hospital. Generally, infants with critical CHD require patency of the ductus arteriosus with infusion of prostaglandin to maintain pulmonary or systemic blood flow. After initial management, the infants must be immediately referred to tertiary care center for definitive intervention.
Keywords: congenital heart disease, duct-dependent circulation, ductus arteriosus, prostaglandin
Authors
- Herick Alvenus Willim1*
- Cristianto2
- Alice Inda Supit3
- 1General Practitioner, Dr. Agoesdjam Regional Public Hospital, West Kalimantan, Indonesia
- 2General Practitioner, Dr Agoesdjam Public Hospital, Ketapang, Indonesia
- 3Department of Cardiology and Vascular, Dr Soedarso Regional Public Hospital, Pontianak, Indonesia
Corresponding author Herick Alvenus Willim — herick_alvenus@yahoo.co.id
Article history
- Submitted
- Accepted
- Published
Downloads
Published
Issue
Section
License
Copyright and licensing
Copyright in each article remains with the author(s). Authors grant Bioscientia Medicina: Journal of Biomedicine and Translational Research a non-exclusive right of first publication and the right to identify itself as the original publisher. No exclusive transfer of copyright is required.
All articles are published under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (CC BY-NC-SA 4.0): https://creativecommons.org/licenses/by-nc-sa/4.0/. Users may copy, redistribute, remix, transform, and build upon the material for non-commercial purposes, provided appropriate attribution is given, a link to the license is supplied, changes are indicated, and adaptations are distributed under the same license.
The license applies to the article's scholarly content unless a credit line states otherwise. Third-party material may be subject to separate rights. Authors retain patent, trademark, moral, and research-data rights. The copyright year follows the article's publication date.
